Search Results - "Morton, Stuart"

Refine Results
  1. 1
  2. 2

    Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis by Spirli, Carlo, Locatelli, Luigi, Morell, Carola M, Fiorotto, Romina, Morton, Stuart D, Cadamuro, Massimiliano, Fabris, Luca, Strazzabosco, Mario

    Published in Hepatology (Baltimore, Md.) (01-11-2013)
    “…Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney…”
    Get full text
    Journal Article
  3. 3

    QSAR Model of Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain: Incorporating P-glycoprotein Efflux as a Variable by Dolgikh, Elena, Watson, Ian A, Desai, Prashant V, Sawada, Geri A, Morton, Stuart, Jones, Timothy M, Raub, Thomas J

    “…We report development and prospective validation of a QSAR model of the unbound brain-to-plasma partition coefficient, Kp,uu,brain, based on the in-house data…”
    Get full text
    Journal Article
  4. 4

    Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials by Ratitch, Bohdana, Rodriguez-Chavez, Isaac R., Dabral, Abhishek, Fontanari, Adriano, Vega, Julio, Onorati, Francesco, Vandendriessche, Benjamin, Morton, Stuart, Damestani, Yasaman

    Published in Digital biomarkers (01-09-2022)
    “…Background: The proliferation and increasing maturity of biometric monitoring technologies allow clinical investigators to measure the health status of trial…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances by Bercu, Joel P., Morton, Stuart M., Deahl, J. Thom, Gombar, Vijay K., Callis, Courtney M., van Lier, Robert B.L.

    Published in Regulatory toxicology and pharmacology (01-07-2010)
    “…The current risk assessment approach for addressing the safety of very small concentrations of genotoxic impurities (GTIs) in drug substances is the threshold…”
    Get full text
    Journal Article
  8. 8

    Efficiency Gains in Tracer Identification for Nuclear Imaging: Can In Vivo LC-MS/MS Evaluation of Small Molecules Screen for Successful PET Tracers? by Joshi, Elizabeth M, Need, Anne, Schaus, John, Chen, Zhaogen, Benesh, Dana, Mitch, Charles, Morton, Stuart, Raub, Thomas J, Phebus, Lee, Barth, Vanessa

    Published in ACS chemical neuroscience (17-12-2014)
    “…Positron emission tomography (PET) imaging has become a useful noninvasive technique to explore molecular biology within living systems; however, the utility…”
    Get full text
    Journal Article
  9. 9

    How well do lipophilicity parameters, MEEKC microemulsion capacity factor, and plasma protein binding predict CNS tissue binding? by Zamek-Gliszczynski, Maciej J, Sprague, Karen E, Espada, Alfonso, Raub, Thomas J, Morton, Stuart M, Manro, Jason R, Molina-Martin, Manuel

    Published in Journal of pharmaceutical sciences (01-05-2012)
    “…Brain fraction unbound (Fu) is critical to understanding the pharmacokinetics/dynamics of central nervous system (CNS) drugs, thus several surrogate predictors…”
    Get more information
    Journal Article
  10. 10

    Assessing the Impact of Interactive Educational Videos and Screencasts Within Pre-clinical Microanatomy and Medical Physiology Teaching by Robson, Alistair, Scantling-Birch, Yarrow, Morton, Stuart, Anbu, Deepika, Border, Scott

    “…Modern medical curricula adopt the use self-directed learning approaches, which frequently include the use of technology enhanced learning resources. Often,…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Protein kinase a‐dependent pSer675‐β‐catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis by Spirli, Carlo, Locatelli, Luigi, Morell, Carola M., Fiorotto, Romina, Morton, Stuart D., Cadamuro, Massimiliano, Fabris, Luca, Strazzabosco, Mario

    Published in Hepatology (Baltimore, Md.) (01-11-2013)
    “…Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney…”
    Get full text
    Journal Article
  14. 14

    QSAR Model of Unbound Brain-to-Plasma Partition Coefficient, K^sub p,uu,brain^: Incorporating P-glycoprotein Efflux as a Variable by Dolgikh, Elena, Watson, Ian A, Desai, Prashant V, Sawada, Geri A, Morton, Stuart, Jones, Timothy M, Raub, Thomas J

    “…We report development and prospective validation of a QSAR model of the unbound brain-to-plasma partition coefficient, K^sub p,uu,brain^, based on the in-house…”
    Get full text
    Journal Article
  15. 15

    Using Similarity Metrics on Real World Data and Patient Treatment Pathways to Recommend the Next Treatment by Haas, Kyle, Morton, Stuart, Gupta, Simone, Mahoui, Malika

    “…Non-small-cell lung cancer (NSCLC) is one of the most prevalent types of lung cancer and continues to have an ominous five year survival rate. Considerable…”
    Get full text
    Journal Article
  16. 16

    QSAR Model of Unbound Brain-to-Plasma Partition Coefficient, K p,uu,brain: Incorporating P‑glycoprotein Efflux as a Variable by Dolgikh, Elena, Watson, Ian A, Desai, Prashant V, Sawada, Geri A, Morton, Stuart, Jones, Timothy M, Raub, Thomas J

    “…We report development and prospective validation of a QSAR model of the unbound brain-to-plasma partition coefficient, K p,uu,brain, based on the in-house data…”
    Get full text
    Journal Article
  17. 17

    Protein kinase a-dependent pSer675-[beta]-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis by Spirli, Carlo, Locatelli, Luigi, Morell, Carola M, Fiorotto, Romina, Morton, Stuart D, Cadamuro, Massimiliano, Fabris, Luca, Strazzabosco, Mario

    Published in Hepatology (Baltimore, Md.) (01-11-2013)
    “…Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney…”
    Get full text
    Journal Article
  18. 18

    PKA dependent p-Ser-675β-catenin, a novel signaling defect in a mouse model of Congenital Hepatic Fibrosis by Spirli, Carlo, Locatelli, Luigi, Morell, Carola M., Fiorotto, Romina, Morton, Stuart D., Cadamuro, Massimiliano, Fabris, Luca, Strazzabosco, Mario

    Published in Hepatology (Baltimore, Md.) (30-09-2013)
    “…Genetically-determined loss of fibrocystin function causes Congenital Hepatic Fibrosis (CHF), Caroli Disease (CD) and Autosomal Recessive Polycystic Kidney…”
    Get full text
    Journal Article
  19. 19

    Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies by Cadamuro, Massimiliano, Morton, Stuart Duncan, Strazzabosco, Mario, Fabris, Luca

    Published in Psychologia latina (01-07-2013)
    “…Cholangiocarcinoma (CCA) is a very aggressive neoplasm, whose incidence has steadily increased in the last decade. Despite its growing epidemiological impact,…”
    Get full text
    Journal Article
  20. 20